Nutritional hormesis

European Journal of Clinical Nutrition

Volumn 61, Issue 2, 2007, Pages 147-159

  Hayes, D P ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; ADENOSINE RECEPTOR STIMULATING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ANDROGEN; ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHLORPHENOTANE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN DERIVATIVE; FLAVANOID; HERBICIDE; ISOTHIOCYANIC ACID DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MINERAL; OPIATE AGONIST; PEPTIDE DERIVATIVE; PESTICIDE; PROANTHOCYANIDIN; PROSTAGLANDIN DERIVATIVE; RESVERATROL; RETINOL; SELENIUM; SEROTONIN AGONIST; SYNTHETIC PEPTIDE; TRACE ELEMENT; UNINDEXED DRUG; VITAMIN;

ALCOHOL CONSUMPTION; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN TOXICITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER RISK; CELL PROLIFERATION; DIET RESTRICTION; DRUG MEGADOSE; HEART PROTECTION; HORMESIS; HORMONAL REGULATION; HUMAN; LIVER INJURY; LOW DRUG DOSE; NONHUMAN; NUTRIENT; NUTRITIONAL HEALTH; NUTRITIONAL SCIENCE; NUTRITIONAL VALUE; PROTEIN SYNTHESIS INHIBITION; RETINOL DEFICIENCY; REVIEW;

BIOLOGY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MINERALS; NUTRITION POLICY; PESTICIDES; TOXICOLOGY; VITAMINS;

EID: 33846981139     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602507     Document Type: Review

References (108)

1. Ames BN (1998). Micronutrients prevent cancer and delay aging. Toxicol Lett 102-103, 5-18.
2. Ames BN, Gold IS (2000). Paracelsus to parascience: The environmental cancer distraction. Mutat Res 447, 3-13.
3. Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A et al. (2003). Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from caloric intake. Proc Natl Acad Sci USA 100, 6216-6220.
4. Attaran A, Maharaj R (2000). DDT for malaria control should not be banned. Br Med J 321, 1403-1404.
5. Blardi P, De Lalla A, Volpi L, Di Perri T (1999). Stimulation of endogenous adenosine release of oral administration of quercetin and resveratrol in man. Drugs Exp Clin Res 25, 105-110.
6. Bluher M, Kahn BB, Kahn CR (2003). Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572-574
7. Bodner KM, Collins JJ, Bloemen LJ, Carson ML (2003). Cancer risk for chemical workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 60, 672-675.
8. Brandes LJ (2005). Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: In vivo correlates. Crit Rev Toxicol 35, 587-592.
9. Branham SE (1929). The effects of certain chemical compounds upon the course of gas production by Baker's yeast. J Bacteriol 18, 247-284.
10. Calabrese EJ (1999). Evidence that hormesis represents an 'overcompensation' response to a disruption in homeostasis. Ecotoxicol Environ Saf 42, 135-137.
11. Calabrese EJ (2001). Apoptosis: Biphasic dose responses, Crit Rev Toxicol 31 (4&5), 607-613.
12. Calabrese EJ (2004). Hormesis: From marginalization to mainstream A case for hormesis as the default dose-response model in risk assessment. Toxicol Appl Pharmacol 197, 125-136.
13. Calabrese EJ (2005a). The hormetic challenge. Presentation at the 2005 BELLE Conference. University of Massachusetts, Amherst, MA.
14. Calabrese EJ (2005b). Cancer biology and hormesis: Human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol 35, 463-582.
15. Calabrese EJ (2005c). Hormetic dose-response relationships in immunology: Occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol 35, 89-295.
16. Calabrese EJ, Baldwin LA (1997). The dose determines the stimulation (and poison): Development of a chemical hormesis database. Int J Toxicol 16, 545-559.
17. Calabrese EJ, Baldwin LA (2001a). Agonist concentration gradients as a generalizable regulatory implementation strategy. Crit Rev Toxicol 31, 471-473.
18. Calabrese EJ, Baldwin LA (2001b). The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 62, 330-338.
19. Calabrese EJ, Baldwin LA (2002). Defining hormesis. Hum Exp Toxicol 21, 91-97.
20. Calabrese EJ, Baldwin LA (2003a). The hormetic dose response model is more common than the threshold model in toxicology. Toxicol Sci 71, 246-250.
21. Calabrese EJ, Baldwin LA (2003b). Hormesis: The dose-response revolution. Ann Rev Pharmacol Toxicol 43, 175-197.
22. Calabrese EJ, Baldwin LA (2003c). Ethanol and hormesis. Crit Rev Toxicol 33 (3&4), 407-424.
23. Calabrese EJ, Blain R (2004). The hormetic database: An overview. Toxicol Appl Pharmacol 202, 289-300.
24. Calabrese EJ, Staudenmayer JW, Stanek EJ (2006). Drug development and hormesis: Changing conceptual understanding of the dose response creates new challenges and opportunities for more effective drugs. Curr Opin Drug Disc Dev 9, 117-123.
25. Cole P, Trichopoulos D, Pastides H, Starr T, Mandel JS (2003). Dioxin and cancer; a critical review. Regul Toxicol Pharmacol 38, 378-388.
26. Collins JJ, Swaen GMH, Marsh GM, Utidjian HM, Caporossi JC, Lucas LJ (1989). Mortality patterns among workers exposed to acrylamide. J Occup Med 31, 614-617.
27. Committee on Medical Aspects of Food and Nutrition Policy - COMA (1998). Epidemiology of diet in relation to specific cancers. Department of Health Report and Social Subjects No. 48: Nutritional Aspects of the Development of Cancer. Stationery Office: London, England.
28. Cook RR (1994). Response in humans to low level exposure. In: Calabrese EJ (ed). Biological Effects of Law Level Exposures: Dose-Response Relationships. Lewis Publishers: Boca Raton, FL, pp 99-109.
29. Crump KS, Canady R, Kogevinas M (2003). Meta-analysis of dioxin cancer dose response for three occupational cohorts. Environ Health Perspect 111, 681-687.
30. Davis HC, Hidu H (1969). Effects of pesticides on embryonic development of clams and oysters and on survival of growth of the larvae. Fish Bull 67, 393-404.
31. Davis JM, Svendsgaard DJ (1990). U-shaped dose-response curves: Their occurrence and implications for risk assessment. J Toxicol Envir Health 30, 71-83.
32. Eaton DL, Klaassen CD (2001). Principles of toxicology. In: Klaassen CD (ed). Casarett and Doull's Toxicology. The Basic Science of Poisons, 6th edn, Chapter 2, McGraw-Hill: New York.
33. Fan F, Wierda D, Rozman KK (1996). Effects of 2,3,7,8-tetrachorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats. Toxicology 106, 221-228.
34. Faulkner K, Mithen R, Williamson G (1998). Selective increase of the potential anticarcinogen 4-methylsulphinylbutyl glucosinolate in broccoli. Carcinogenesis 19, 605-609.
35. Fontana L, Meyer TE, Klein S, Holloszy JO (2004). Long-term calorie restriction is highly effective in reducing the risk of atherosclerosis in humans. Proc Natl Acad Sci USA 101, 6659-6663.
36. Gaziano JM, Buring JE (1998). Alcohol intake, lipids, and the risks of myocardial infarction (with discussion). In: Chadwick DJ, Goode JA (eds). Alcohol and Cardiovascular Diseases. Wiley: Chichester, UK, pp 86-110.
37. Gold LS, Sloane TH, Manley NB, Ames BN (2003). Misconceptions About the Causes of Cancer. The Fraser Institute: Vancouver BC, Canada.
38. Gronbaek M (2004). Epidemiologic evidence for the cardioprotective effects associated with consumption of alcoholic beverages. Pathophysiology 10, 83-92.
39. Haley-Zitlin V, Richardson A (1993). Effect of dietary restriction on DNA damage repair and DNA damage. Mutat Res 295, 237-245.
40. Hallengren B, Forsgren A (1978). Effect of alcohol on chemotaxis, adherence and phagocytosis of human polymorphonuclear leucocytes. Acta Med Scand 204, 43-48.
41. Hayes DP (2005). The protective role of fruits and vegetables against radiation-induced cancer. Nutr Rev 63, 303-311.
42. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
43. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003). Calorie restriction, aging, and cancer prevention: Mechanisms of action and applicability to humans. Annu Rev Med 54, 131-152.
44. Johnson TE, Bruunsgaard H (1998). Implication of hormesis for biomedical aging and research. Hum Exp Toxicol 17, 263-265.
45. Kaiser J (2003). Sipping from a poisoned chalice. Science 302, 376-379.
46. Kayajanian GM (1999). Dioxin is a systematic promoter blocker, II. Ecotoxicol Environ Saf 42, 103-109.
47. Kayajanian GM (2000). Southeast Asia, promotability and dioxin's relationship to cancer incidence in operation ranch hand veterans. Ecotoxicol Environ Saf 46, 125-129.
48. Kayajanian GM (2001). Dioxin body burdens in operation ranch hand veterans: Promotion blocking and cancer causation. Ecotoxicol Environ Saf 50, 167-173.
49. Kayajanian GM (2002). The J-shaped dioxin dose response curve. Ecotoxicol Environ Saf 51, 1-4.
50. Keenan RE, Paustenbach DJ, Wenning RJ, Parsons AH (1991). Pathology reevaluation of the Kociba et al. (1978) bioassay of 2,3,7,8-TCDD: implications for risk assessment. J Toxicol Environ Health 34, 279-296.
51. Key T, Reeves G (1994). Organochlorines in the environment and breast cancer. Br Med J 308, 1520-1521.
52. Klaunig JE (2005). Cancer biology and hormesis: Commentary. Crit Rev Toxicol 35, 593-594.
53. Kociba RJ, Keyes DG, Bayer JE, Carreon RM, Wade CE, Dittenber DA et al. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetarchorodibenzeo-dioxin in rats. Toxicol Appl Pharmacol 46, 279-303.
54. Kociba RJ, Schwetz BA (1982). Toxicity of 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD). Drug Metab Rev 13, 387-406.
55. Korthuis RJ (2004). Introduction to the special topics issue on alcohol and cardioprotection. Pathophysiology 10, 81-82.
56. Kushida M, Sukata T, Uwagawa S, Ozaki K, Kinoshita A, Wanibuchi H et al. (2005). Low dose DDT inhibition of hepatocarcinogenesis initiated by diethlnitrosamine in male rats: Possible mechanisms. Toxicol Appl Pharmacol 208, 285-294.
57. Lindquist S (1986). The heat shock response. Annu Rev Biochem 55, 1151-1191.
58. Marsh GM, Lucas LJ, Youk AO, Schall LC (1999). Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup Environ Med 56, 181-190.
59. Masoro EJ (1998). Hormesis and the antiaging action of dietary restriction. Exp Gerontol 33, 61-66.
60. Masoro EJ (2003). Subfield history: Caloric restriction, slowing aging, and extending life. Sci Aging Knowledge Environ 8, RE2.
61. Mattson MP (2005). Hormesis and disease resistance: Activation of cellular stress response pathways. BELLE Newsletter 13 (No. 2, Part 2), pp 6-14.
62. Mattson MP, Chan SL, Duan W (2002). Modification of brain imaging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82, 637-672.
63. Melzer K, Kayser B, Pichard C (2004). Physical activity: The health benefits outweigh the risks. Curr Opin Clin Nub Metab Care 7, 641-647.
64. Mertz W (1981). The essential trace elements. Science 213, 580-583.
65. Meyer TE, Kovacs S, Ehsani AA, Klein S, Holloszy JO, Fontana L (2006). Long-term caloric restriction ameliorates the decline of diastolic functions in humans. J Am Coll Cardiol 47, 398-402.
66. Milner JA (2002). Strategies for cancer prevention: The role of diet. Br J Nutr 87 (Suppl 2), S265-S272.
67. Morse JG (1998). Agricultural implications of pesticide-induced hormesis of insects and mites. Hum Exp Toxicol 17, 266-269.
68. Mucci LA, Adami H-O, Wolk A (2006). Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 118, 169-173.
69. Mucci LA, Dickman PW, Steineck G, Adami H-O, Augustsson K (2003a). Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 88, 84-89.
70. Mucci LA, Dickman PW, Steineck G, Adami H-O, Augustsson K (2003b). Reply: Dietary acrylamide and Aancer risk: additional data on coffee. Br J Cancer 89, 775-776.
71. Mucci LA, Linblad P, Steineck G, Adami H-O (2004). Dietary acrylamide and risk of renal cell cancer. Int J Cancer 109, 774-776.
72. Mucci LA, Sandin S, Balter K, Adami H-O, Magnusson C, Weiderpass E (2005). Acrylamide intake and breast cancer risk in Swedish women. J Am Med Assoc 293, 1326-1327.
73. Parsons PA (2000). Caloric restriction, metabolic efficiency and hormesis. Hum Exp Toxicol 19, 345-347.
74. Paustenbach DJ, Layard MW, Wenning RJ, Keenan RE (1991). Risk assessment of 2,3,7,8-TCDD using a biologically based cancer model: A reevaluation of the Kociba et al. bioassay using 1978 and 1990 histopathology criteria. J Toxicol Environ Health 34, 11-26.
75. Pavuk M, Michalek JE, Ketchum NS (2006). Prostate cancer in US Air Force veterans of the Vietnam War. J Expo Anal Environ Epidemiol 16, 184-190.
76. Pelucchi C, Galeone C, Levi F, Negri E, Franceschi S, Talamini R et al. (2006). Dietary acrylamide and human cancer. Int J Cancer 118, 467-471.
77. Pelucchi CS, Franceschi S, Levi F, Trichopoulos D, Bosetti C, Negri E et al. (2003). Fried potatoes and human cancer. Int J Cancer 105, 558-560.
78. Pohorecky LA (1977). Biphasic action of ethanol. Biobehav Rev 1, 231-240.
79. Pool-Zobel BL, Dornacher I, Lambertz R, Knoll M, Seitz HK (2004). Genetic damage and repair in human rectal cells for biomonitoring: Sex differences, effects of alcohol exposure, and susceptibilities in comparison to peripheral blood lymphocytes. Mut Res 551, 127-134.
80. Potter JD, Steinmetz K (1996). Vegetables, fruit and phytoestrogens as preventive agents. In: Stewart BW, McGregor D and Kleihues P (eds). Principles of Chemoprevention. International Agency for Research on Cancer, Publication No. 139: Lyon, France, pp 61-90.
81. Raji NS, Surekha A, Rao KS (1998). Improved DNA-repair parameters in PHA-stimulated peripheral blood lymphocytes of human subjects with low body mass. Mech Ageing Dev 104, 133-148.
82. Rattan SI (2001). Applying hormesis in aging research and therapy. Hum Exp Toxicol 20, 281-285; discussion 293-294.
83. Rattan SI (2004). Aging intervention, prevention, and therapy through hormesis. J Geriatrics: Biol Sci 59A, 705-709.
84. Rehm J (2000). Alcohol consumption and mortality: What do we know and where should we go? Addiction 95, 989-995.
85. Rico A (2002). Chemo-defence system. C R Acad Sci III 324, 97-106.
86. Rimm EB, Klatsky AL, Grobbee D, Stampfer MJ (1996). Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? Br Med J 312, 731-736.
87. Roth GS, Ingram DK, Land MA (1999). Calorie restriction in primates: will it work and how will we know? J Am Geriatrics Soc 47, 896-903.
88. Safe S, Wargowich MJ, Lamartiniere CA, Mukhtar H (1999). Forum: symposium on mechanisms of action of naturally occurring anticarcinogens. Toxicol Sci 52, 1-8.
89. Sato M, Fraga C, Das D (2004). Induction of the expression of cardioprotective proteins after mild-to-moderate consumption of alcohol. Pathophysiology 10, 139-148.
90. Sauvaget C, Kasagi F, Waldren C (2004). Dietary factors and cancer mortality among atomic-bomb survivors. Mutat Res 551, 145-152.
91. Sauvaget C, Nagano J, Hayashi M, Spencer E, Shimizu Y, Allen N (2003). Vegetable and fruit intake and cancer mortality in the Hiroshima/ Nagasaki life span study. Br J Cancer 88, 689-694.
92. Standridge JB, Zylstra RG, Adams SM (2004). Alcohol consumption: An overview of benefits and risks. South Med J 97, 664-672.
93. Starr TB (2003). Significant issues raised by meta-analyses of cancer mortality and dioxin exposure. Environ Health Perspect 111, 1443-1447.
94. Stebbing ARD (1982). Hormesis - the stimulation of growth by low levels of inhibitors. Sci Total Environ 22, 213-234.
95. Stebbing ARD (2003). A mechanism for hormesis - a problem in the wrong discipline. Crit Rev Toxicol 33 (3&4), 463-467.
96. Steinmetz KA, Potter JD (1996). Vegetables, fruit, and cancer prevention: A review. J Am Diet Assoc 96, 1027-1039.
97. Strom A, Jensen RA (1951). Mortality from circulating diseases in Norway 1940-1945. Lancet 1, 126-129.
98. Sukata T, Uwagawa S, Ozaki K, Ogawa M, Nishikawa T, Iwai S et al. (2002). Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int J Cancer 99, 112-118.
99. Beers MH, Berkow R (eds) (1999). The Merck Manual of Diagnosis and Therapy 17th edn, Chapters 3 and 4. Merck Research Laboratory: Whitehouse Station, NJ.
100. Tissenbaum HA, Guarente L (2001). Increased dosage of sir-2 extends lifespan of Caenorhabditis elegans. Nature 410, 227-230.
101. Townsend CO (1899). The effects of ether upon the germination of seeds and spores. Bot Gaz 27, 458-466.
102. Tuomisto J, Pekkanen J, Kiviranta. H, Tukiainen E, Vartiainen T, Viluksela M et al. (2005). Dioxin cancer risk - example of hormesis? Dose-Response 3, 332-341.
103. Tuomisto JT, Pekkanen J, Kiviranta H, Tukiainen E, Vartiainen T, Tuomisto J (2004). Soft tissue sarcoma and dioxins - a case control study. Int J Cancer 108, 893-900.
104. Verdery RB, Walford RL (1998). Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch Intern Med 158, 900-906.
105. World Cancer Research Fund, American Institute for Cancer Research - AICR (1997). Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research: Washington, DC.
106. Yerkes RM, Dodson JD (1908). The relation of strength of stimulus to rapidity of habit-formation. J Comp Neurol Psychol 18, 459-482.
107. Yu BP (1994). How diet influences aging process of the rat. Proc Soc Exp Biol Med 205, 97-105.
108. Yu BP, Chung HY (2001). Stress resistance by caloric restriction for longevity. Ann NY Acad Sci 928, 39-47.